Anteris Technologies hails FDA early feasibility study approval for DurAVR™
Digital Asset Direct
by
Anteris Technologies Ltd
Melbourne, Victoria | December 06, 2022 01:00 PM Eastern Standard Time
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744